Literature DB >> 3544335

HLA phenotypes and bullous cutaneous reactions to drugs.

J C Roujeau, C Bracq, N T Huyn, E Chaussalet, C Raffin, N Duédari.   

Abstract

Drug induced toxic epidermal necrolysis and Stevens-Johnson syndrome are weakly associated with HLA-B12. Among patients reacting to a given drug we observed stronger links, especially for HLA-A29; B12; DR7 and sulphonamides.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3544335     DOI： 10.1111/j.1399-0039.1986.tb00491.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN： 0001-2815


  14 in total

1.  Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population.

Authors:  Tais H Wakamatsu; Mayumi Ueta; Katsushi Tokunaga; Yukinori Okada; Renata R Loureiro; Karita A Costa; Juliana Maria F Sallum; José Arthur Milhomens; Chikara Inoue; Chie Sotozono; José Álvaro P Gomes; Shigeru Kinoshita
Journal:  JAMA Ophthalmol       Date:  2017-04-01       Impact factor: 7.389

2.  Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics.

Authors:  Ann M Moyer; Manish J Gandhi
Journal:  Methods Mol Biol       Date:  2022

3.  HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

Authors:  Shuen-Iu Hung; Wen-Hung Chung; Lieh-Bang Liou; Chen-Chung Chu; Marie Lin; Hsien-Ping Huang; Yen-Ling Lin; Joung-Liang Lan; Li-Cheng Yang; Hong-Shang Hong; Ming-Jing Chen; Ping-Chin Lai; Mai-Szu Wu; Chia-Yu Chu; Kuo-Hsien Wang; Chien-Hsiun Chen; Cathy S J Fann; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

Review 4.  Pharmacogenomics of adverse drug reactions.

Authors:  Ann K Daly
Journal:  Genome Med       Date:  2013-01-29       Impact factor: 11.117

5.  Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe.

Authors:  Emmanuelle Génin; Martin Schumacher; Jean-Claude Roujeau; Luigi Naldi; Yvonne Liss; Rémi Kazma; Peggy Sekula; Alain Hovnanian; Maja Mockenhaupt
Journal:  Orphanet J Rare Dis       Date:  2011-07-29       Impact factor: 4.123

6.  Genetic testing for prevention of severe drug-induced skin rash.

Authors:  Ana Alfirevic; Munir Pirmohamed; Branka Marinovic; Linda Harcourt-Smith; Andrea L Jorgensen; Tess E Cooper
Journal:  Cochrane Database Syst Rev       Date:  2019-07-17

Review 7.  Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

Authors:  Rebecca Pavlos; Katie D White; Celestine Wanjalla; Simon A Mallal; Elizabeth J Phillips
Journal:  Immunol Allergy Clin North Am       Date:  2017-11       Impact factor: 3.479

Review 8.  Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review.

Authors:  V L M Yip; A Alfirevic; M Pirmohamed
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 9.  Genetics of Severe Cutaneous Adverse Reactions.

Authors:  Shang-Chen Yang; Chun-Bing Chen; Mao-Ying Lin; Zhi-Yang Zhang; Xiao-Yan Jia; Ming Huang; Ya-Fen Zou; Wen-Hung Chung
Journal:  Front Med (Lausanne)       Date:  2021-07-15

10.  Relationship between human leucocyte antigen class I and class II and chronic idiopathic urticaria associated with aspirin and/or NSAIDs hypersensitivity.

Authors:  Maria Luisa Pacor; Gabriele Di Lorenzo; Pasquale Mansueto; Nicola Martinelli; Maria Esposito-Pellitteri; Paola Pradella; Laura Uxa; Gaetana Di Fede; GiovamBattista Rini; Roberto Corrocher
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.